← ANALYSTS · TIPRANKS
Mayank Mamtani · B. Riley Securities
Hits
38%
192 of 499 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+5.8%
Over a year after the rating, TipRanks’ measure
Our companies rated now
21
Buy / hold / sell: 21 / 0 / 0
Upside of the analyst’s targets
+179.5%
Average over 21 current targets, to the last price
The market’s answer to the ratings
+2.0%
Day-0 move against SPY in the rating’s direction, average over 13 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 24on TipRanks Sep 25 04:07 | LCTXIWMLineage Therap · $232M | Reiterated | Buy | $4.00 | +309.0% | −0.9%next day +8.2% · 5 days −4.1% | ↗ |
| Sep 24on TipRanks 11:35 | AGENIWMAgenus · $302M | Reiterated | Buy | $14.00 | +131.8% | +1.3%next day −0.1% · 5 days −1.6% | ↗ |
| Sep 24on TipRanks 08:40 | ELTXIWMElicio Therapeutics · $48M | Reiterated | Buy | $27.00 → $8.00−70.4% | +412.8% | +0.6%next day −2.7% · 5 days +2.5% | ↗ |
| Sep 11on TipRanks 08:55 | XGNExagen · $200M | Reiterated | Buy | $12.00 | +55.4% | 0.0%next day +5.0% · 5 days +19.7% | ↗ |
| Sep 4on TipRanks 08:30 | CLYMIWMClimb Bio · $627M | Reiterated | Buy | $26.00 → $30.00+15.4% | +205.5% | +6.8%next day +3.0% · 5 days −5.0% | ↗ |
| Sep 2on TipRanks 09:10 | AAPGAscentage Pharma Group International Unsponsored ADR · $1.4B | Reiterated | Buy | $45.00 | +192.8% | +3.1%next day +2.2% · 5 days +0.1% | ↗ |
| Aug 25on TipRanks 08:40 | DNLIIWMDenali Therapeutics · $2.9B | Reiterated | Buy | $30.00 → $35.00+16.7% | +98.8% | +2.7%next day −1.5% · 5 days −6.1% | ↗ |
| Aug 17on TipRanks 09:20 | MGNXIWMMacroGenics · $211M | Reiterated | Buy | $9.00 → $11.00+22.2% | +238.5% | −3.3%next day +1.4% · 5 days +0.2% | ↗ |
| Aug 13on TipRanks 09:35 | UNCYIWMUnicycive Therapeutics · $100M | Reiterated | Buy | $22.00 → $20.00−9.1% | +495.2% | −0.5%next day +2.2% · 5 days +2.9% | ↗ |
| Aug 10on TipRanks 09:16 | HROWIWMHarrow Health · $1.1B | Reiterated | Buy | $60.00 | +119.9% | +0.7%next day −2.8% · 5 days −3.0% | ↗ |
| Aug 10on TipRanks 08:25 | ZYMEIWMZymeworks · $1.8B | Reiterated | Buy | $40.00 → $44.00+10.0% | +75.8% | +2.7%next day +1.0% · 5 days +4.8% | ↗ |
| Aug 7on TipRanks 09:15 | TRVIIWMTrevi Therapeutics · $1.7B | Initiated | Buy | $31.00 | +160.9% | −0.6%next day −3.8% · 5 days −0.7% | ↗ |
| Aug 7on TipRanks 09:01 | NUVBIWMNuvation Bio · $1.7B | Reiterated | Buy | $12.00 → $14.00+16.7% | +214.6% | +7.4%next day 0.0% · 5 days −6.2% | ↗ |
| Jul 31on TipRanks 08:42 | CYTKIWMCytokinetics · $8.9B | Reiterated | Buy | $146 | +135.7% | −4.8%next day −2.3% · 5 days −4.0% | ↗ |
| Jul 15on TipRanks 05:35 | MANEIWMVeradermics, Incorporated · $4.8B | Initiated | Buy | $170 | +56.2% | +11.9%next day −13.9% · 5 days −10.2% | ↗ |
| Jun 29on TipRanks Jun 26 09:05 | KYMRIWMKymera Therapeutics · $9.0B | Assigned | Buy | $117 → $155+32.5% | +47.9% | −6.4%next day −0.5% · 5 days +3.1% | ↗ |
| May 29on TipRanks Jun 1 09:10 | AVBPIWMArriVent BioPharma, Inc. · $828M | Reiterated | Buy | $45.00 | +170.1% | +12.0%next day +1.1% · 5 days +2.8% | ↗ |
| Apr 9on TipRanks 09:00 | NVAXIWMNovavax · $2.1B | Reiterated | Buy | $16.00 → $18.00+12.5% | +59.9% | +0.8%next day −4.9% · 5 days −2.0% | ↗ |
| Mar 18on TipRanks 05:10 | ARCTIWMArcturus Therapeutics · $320M | Initiated | Buy | $22.00 | +112.8% | +3.9%next day +2.8% · 5 days +8.2% | ↗ |
| Feb 23on TipRanks 08:25 | NKTRIWMNektar Therapeutics · $1.3B | Reiterated | Buy | $105 → $150+42.9% | +319.2% | +0.9%next day −7.8% · 5 days −7.7% | ↗ |
| Oct 3on TipRanks 11:05 | SNDXIWMSyndax Pharmaceuticals · $1.2B | Reiterated | Buy | $33.00 | +155.8% | +1.0%next day +4.8% · 5 days +5.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗